Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-13

Clinical Trial Update: StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating StrataGraft skin tissue as an alternative to autografting for deep partial-thickness burns has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • StrataGraft

Snippet

Sponsor: Stratatech, a Mallinckrodt Company | Conditions: Skin Wound, Burns | Phase 1 | Status: COMPLETED | Results posted: 2018-12-13